Screening for Anxiety in Adolescent and Adult Women: A Recommendation From the Women's Preventive Services Initiative

Annals of Internal Medicine
Kimberly D GregoryWomen’s Preventive Services Initiative

Abstract

The Women's Preventive Services Initiative (WPSI), a national coalition of women's health professional organizations and patient representatives, developed a recommendation on screening for anxiety in adolescent and adult women to improve detection; achieve earlier diagnosis and treatment; and improve health, function, and well-being. The WPSI's recommendations are intended to guide clinical practice and coverage of services for the Health Resources and Services Administration and other stakeholders. The target audience for this recommendation includes all clinicians providing preventive health care to women, particularly in primary care settings. This recommendation applies to women and adolescent girls aged 13 years or older who are not currently diagnosed with anxiety disorders, including pregnant and postpartum women. The WPSI developed this recommendation after evaluating results of a systematic review of the effectiveness of screening, accuracy of screening instruments, and benefits and harms of treatments in adolescent girls and adult women. No studies directly evaluated the overall effectiveness or harms of screening for anxiety. Twenty-seven screening instruments and their variations were moderately to highly accurate ...Continue Reading

References

Apr 1, 1997·Journal of the American Academy of Child and Adolescent Psychiatry·B BirmaherS M Neer
Feb 25, 1999·International Journal of Geriatric Psychiatry·C KrasuckiA Mann
Oct 12, 1999·Journal of the American Academy of Child and Adolescent Psychiatry·B BirmaherM Baugher
May 20, 2000·American Journal of Obstetrics and Gynecology·G G EvinsS L Galvin
Aug 15, 2001·Journal of the American Academy of Child and Adolescent Psychiatry·L C DierkerD J Kupfer
Aug 20, 2002·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·F L LopesA E Nardi
May 24, 2003·Journal of Behavior Therapy and Experimental Psychiatry·Evelyn BeharT D Borkovec
Jun 19, 2003·JAMA : the Journal of the American Medical Association·Ronald C KesslerUNKNOWN National Comorbidity Survey Replication
Oct 1, 2003·Journal of Medical Internet Research·Peter FarvoldenPaula Ravitz
Jul 12, 2005·Journal of Anxiety Disorders·Ovsanna T LeyferJanet Woodruff-Borden
May 24, 2006·Archives of Internal Medicine·Robert L SpitzerBernd Löwe
Nov 11, 2006·International Journal of Geriatric Psychiatry·Julie Loebach WetherellJürgen Unützer
Mar 6, 2007·The Journal of Clinical Psychiatry·Jonathan R T Davidson, Michael E Thase
Mar 14, 2007·The Journal of Clinical Psychiatry·Jonathan R T Davidson
Apr 30, 2008·International Journal of Psychiatry in Medicine·Sophie PuddifootJane M Gunn
Feb 24, 2009·Behaviour Research and Therapy·Denise H M BoddenPeter Muris
Jul 10, 2009·The Cochrane Database of Systematic Reviews·Jonathan C IpserLara Hoppe
Jul 28, 2009·Journal of Medical Internet Research·Tara DonkerPim Cuijpers
Dec 10, 2009·Psychosomatics·Kurt KroenkeBernd Löwe
Nov 17, 2010·Journal of Affective Disorders·Rose Meades, Susan Ayers
Nov 23, 2010·International Clinical Psychopharmacology·Miny SamuelStephen M Beard
Dec 15, 2010·The Cochrane Database of Systematic Reviews·Giuseppe GuaianaAndrea Cipriani
Dec 15, 2010·The Cochrane Database of Systematic Reviews·Anna M DeppingStefan Leucht
Jun 13, 2012·Paediatric and Perinatal Epidemiology·Sheila McDonaldSuzanne Tough
Aug 7, 2012·International Journal of Methods in Psychiatric Research·Ronald C KesslerHans-Ullrich Wittchen
Nov 8, 2012·Journal of Women's Health·Michael W O'HaraDenise D'Angelo
Jun 5, 2013·The Cochrane Database of Systematic Reviews·Anthony C JamesAislinn Choke
Sep 11, 2013·The Cochrane Database of Systematic Reviews·Evan Mayo-Wilson, Paul Montgomery
Apr 5, 2014·Archives of Women's Mental Health·Susanne SomervilleAndrew C Page
May 16, 2014·The Australian and New Zealand Journal of Psychiatry·William BorReza Hayatbakhsh
Jul 12, 2014·The Spanish Journal of Psychology·Iva TendaisBárbara Figueiredo
Dec 11, 2014·Clinical Practice and Epidemiology in Mental Health : CP & EMH·Cosme Alvarado-EsquivelCarlos Salas-Martinez
Mar 13, 2015·Psychiatry and Clinical Neurosciences·Mihoko Shimada-SugimotoJohn M Hettema
Mar 21, 2015·Journal of the American Academy of Child and Adolescent Psychiatry·Anne Rifkin-GraboiAnqi Qiu
May 2, 2015·International Clinical Psychopharmacology·Borwin BandelowDirk Wedekind
Jul 1, 2015·Journal of Women's Health·Shaila MisriElena Swift

❮ Previous
Next ❯

Citations

Jun 9, 2020·Annals of Internal Medicine·Kim G Smolderen, Matthew M Burg
Jul 30, 2020·Journal of Women's Health·Kurt Kroenke
Feb 13, 2021·Obstetrics and Gynecology Clinics of North America·Jennifer L Payne
Feb 3, 2021·Journal of Primary Care & Community Health·Danielle J O'LaughlinJohanna Tweedy
Apr 25, 2021·Women's Health Issues : Official Publication of the Jacobs Institute of Women's Health·Sandraluz Lara-CinisomoAmy L Non
Sep 4, 2021·Pediatrics·Alex R KemperEric M Butter

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.